Literature DB >> 11504643

Toward the identification of selective modulators of protein kinase C (PKC) isozymes: establishment of a binding assay for PKC isozymes using synthetic C1 peptide receptors and identification of the critical residues involved in the phorbol ester binding.

M Shindo1, K Irie, A Nakahara, H Ohigashi, H Konishi, U Kikkawa, H Fukuda, P A Wender.   

Abstract

Conventional and novel protein kinase C (PKC) isozymes contain two cysteine-rich C1 domains (C1A and C1B), both of which are candidate phorbol-12,13-dibutyrate (PDBu) binding sites. We previously synthesized C1 peptides (of approximately 50 residues) corresponding to all PKC isozymes and measured their PDBu binding affinity. While many of these peptide receptors exhibited PDBu affinities comparable to the respective complete isozyme, some of the C1A peptides could not be used because they undergo temperature dependent inactivation. This problem was however eliminated by 4 degrees C incubation or elongation of the 50-mer C1 peptides at both N- and C-termini to increase their folding efficiency and stability. These findings enabled us to determine the K(d)'s of PDBu for all PKC C1 peptides (except for theta-C1A) and establish the value of these peptides as readily available, stable, and easily handled surrogates of the individual isozymes. The resultant C1 peptide receptor library can be used to screen for new ligands with PKC isozyme and importantly C1 domain selectivity. Most of the C1 peptide receptors showed strong PDBu binding affinities with K(d)'s in the nanomolar range (0.45-7.4 nM). Two peptides (delta-C1A and theta-C1A) bound PDBu over 100-fold less tightly. To identify the residues that contribute to this affinity difference, several mutants of delta-C1A and theta-C1A were synthesized. Both the G9K mutant of delta-C1A and the P9K mutant of theta-C1A showed K(d)'s of 2-3 nM. This approach provides a useful procedure to determine the role of each C1 domain of the PKC isozymes by point mutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504643     DOI: 10.1016/s0968-0896(01)00100-6

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta.

Authors:  Agnes Czikora; Satyabrata Pany; Youngki You; Amandeep S Saini; Nancy E Lewin; Gary A Mitchell; Adelle Abramovitz; Noemi Kedei; Peter M Blumberg; Joydip Das
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-01-06       Impact factor: 3.747

2.  Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines.

Authors:  Ying Han; Zhe-Yi Han; Xin-Min Zhou; Ru Shi; Yue Zheng; Yong-Quan Shi; Ji-Yan Miao; Bo-Rong Pan; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Diacylglycerol-dependent binding recruits PKCtheta and RasGRP1 C1 domains to specific subcellular localizations in living T lymphocytes.

Authors:  Silvia Carrasco; Isabel Merida
Journal:  Mol Biol Cell       Date:  2004-04-02       Impact factor: 4.138

4.  Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity.

Authors:  Agnes Czikora; Daniel J Lundberg; Adelle Abramovitz; Nancy E Lewin; Noemi Kedei; Megan L Peach; Xiaoling Zhou; Raymond C Merritt; Elizabeth A Craft; Derek C Braun; Peter M Blumberg
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

5.  Synthesis and Evaluation of Dimeric Derivatives of Diacylglycerol-Lactones as Protein Kinase C Ligands.

Authors:  Nami Ohashi; Ryosuke Kobayashi; Wataru Nomura; Takuya Kobayakawa; Agnes Czikora; Brienna K Herold; Nancy E Lewin; Peter M Blumberg; Hirokazu Tamamura
Journal:  Bioconjug Chem       Date:  2017-07-21       Impact factor: 4.774

6.  The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.

Authors:  Tihomir Miralem; Nicole Lerner-Marmarosh; Peter E M Gibbs; Cicerone Tudor; Fred K Hagen; Mahin D Maines
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

7.  Preventative effects of a HIF inhibitor, 17-DMAG, on partial bladder outlet obstruction-induced bladder dysfunction.

Authors:  Nao Iguchi; M İrfan Dönmez; Anna P Malykhina; Alonso Carrasco; Duncan T Wilcox
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-02

Review 8.  Protein kinase C, an elusive therapeutic target?

Authors:  Daria Mochly-Rosen; Kanad Das; Kevin V Grimes
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

9.  Two new lyngbyatoxin derivatives from the Cyanobacterium, Moorea producens.

Authors:  Weina Jiang; Satoshi Tan; Yusuke Hanaki; Kazuhiro Irie; Hajime Uchida; Ryuichi Watanabe; Toshiyuki Suzuki; Bryan Sakamoto; Michiya Kamio; Hiroshi Nagai
Journal:  Mar Drugs       Date:  2014-12-01       Impact factor: 5.118

10.  A new lyngbyatoxin from the Hawaiian cyanobacterium Moorea producens.

Authors:  Weina Jiang; Wei Zhou; Hajime Uchida; Masayuki Kikumori; Kazuhiro Irie; Ryuichi Watanabe; Toshiyuki Suzuki; Bryan Sakamoto; Michiya Kamio; Hiroshi Nagai
Journal:  Mar Drugs       Date:  2014-05-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.